|
2025
|
Invention
|
Pharmaceutically acceptable salt of dihydropyridopyrimidine derivative, and crystal form and use ... |
|
|
Invention
|
Norbornane derivative and pharmaceutical use thereof. The present disclosure relates to a norborn... |
|
|
Invention
|
Amino-substituted heteroaromatic cyclic compound, preparation method therefor and use thereof in ... |
|
|
Invention
|
Benzene ring derivative and pharmaceutical use thereof. The present disclosure relates to a benze... |
|
|
Invention
|
Protein containing t cell receptor constant region and medical use thereof. The present disclosur... |
|
|
Invention
|
Dihydrofuro[3,4-f]quinazoline compound, preparation method therefor and use thereof in medicine. ... |
|
|
Invention
|
Method for treating tslp-associated inflammatory disease using anti-tslp antibody. Provided is a ... |
|
|
Invention
|
Anti-cldn6 antibody, antibody-drug conjugate comprising same and medical use thereof. The present... |
|
|
Invention
|
Preparation method for selective estrogen receptor degrader. Provided is a preparation method for... |
|
|
Invention
|
Anti-nectin-4 antibody-drug conjugate for treating tumor. An anti-Nectin-4 antibody-drug conjugat... |
|
|
Invention
|
Pd-1 binding protein and pharmaceutical use. The present disclosure relates to a PD-1 binding pro... |
|
|
Invention
|
Use of anti-angptl3 antibody in treating hyperlipidemia and method. The present invention relates... |
|
|
Invention
|
Use of eribulin derivative drug conjugate in treatment of tumor. The present invention provides a... |
|
|
Invention
|
Crystalline form and salt of pyridine-n-oxide derivative, and use thereof. The present disclosure... |
|
|
Invention
|
Method for preparing sulfonylurea derivative. The present disclosure relates to a method for prep... |
|
|
Invention
|
Amylin analogue and pharmaceutical use thereof. Provided are an amylin analogue and a pharmaceuti... |
|
|
Invention
|
Anti-cd79b antibody-drug conjugate combined with immunotherapeutic agent and chemotherapeutic age... |
|
|
Invention
|
Method for preparing benzodioxane or salts thereof. The present disclosure relates to a method fo... |
|
|
Invention
|
Anti-cldn6 antibody, antibody-drug conjugate thereof, and medical use thereof. Provided are an an... |
|
|
Invention
|
Pharmaceutical composition comprising selective estrogen receptor degrader, and preparation metho... |
|
|
Invention
|
Pharmaceutically acceptable salt of g12d inhibitor compound and crystal form thereof. The present... |
|
|
Invention
|
Crystal form of g12d inhibitor compound and preparation method. The present invention relates to ... |
|
|
Invention
|
Glp-1r agonist pharmaceutical composition and use thereof. Disclosed are a GLP-1R agonist pharmac... |
|
2024
|
Invention
|
Crystal of nitrogen-bridged heterocyclic compound and prepration method therefor. The present inv... |
|
|
Invention
|
Antibody-polypeptide conjugate and pharmaceutical use thereof. An antibody-polypeptide conjugate ... |
|
|
Invention
|
Quaternary ammonium compound and pharmaceutical use thereof. The present disclosure relates to a ... |
|
|
Invention
|
Phosphate compound of substituted pyrazoline azo derivative or pharmaceutically acceptable salt t... |
|
|
Invention
|
Tetrahydroisoquinoline and pharmaceutical use thereof. The present disclosure relates to tetrahyd... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding dll3 and cd3. Prov... |
|
|
Invention
|
Olefin compound, preparation method therefor and use thereof in medicine. The present disclosure ... |
|
|
Invention
|
Cd3-targeting antibody and use thereof. The present invention provides an antibody specifically b... |
|
|
Invention
|
Method for treating metabolic diseases and pharmaceutical use of glp-1 analogue. A method for tre... |
|
|
Invention
|
Method for treating tumors with anti-her3 antibody drug conjugate and anti-vegf antibody. A metho... |
|
|
Invention
|
Heterocyclic compound, and preparation method therefor and use thereof in medicine. The present d... |
|
|
Invention
|
Method for preparing heterologous multimer by means of recombination reaction. The present disclo... |
|
|
Invention
|
Trgv9 binding proteins and medical use thereof. The present disclosure relates to TRGV9 binding p... |
|
|
Invention
|
Fused heteroaryl compound, preparation method therefor, and use thereof in medicine. The present ... |
|
|
Invention
|
Pharmaceutical composition of sulfonylurea derivative. The present disclosure provides a pharmace... |
|
|
Invention
|
Pharmaceutical composition comprising anti-tslp antibody and use thereof. The present invention r... |
|
|
Invention
|
Amide-substituted cycloalkyl compounds, preparation method therefor and medical uses thereof. The... |
|
|
Invention
|
Pharmaceutically acceptable salt and crystalline form of quinazoline derivative, and use thereof.... |
|
|
Invention
|
Crystalline form of quinazoline derivative and preparation method therefor. A crystalline form of... |
|
|
Invention
|
Heterocyclic compound, preparation method therefor and medical use thereof. The present disclosur... |
|
|
Invention
|
Use of anti-her3 antibody-drug conjugate in treating tumors and method for treating tumors using ... |
|
|
Invention
|
Heteroaryl compound, and preparation method therefor and use thereof in medicine. Provided are a ... |
|
|
Invention
|
Her3/met binding molecule and pharmaceutical use thereof. The present disclosure relates to a HER... |
|
|
Invention
|
Pharmaceutical composition comprising bispecific antibody specifically binding to gprc5d and cd3.... |
|
|
Invention
|
Macrocyclic compound and use thereof. The present disclosure relates to a macrocyclic compound an... |
|
|
Invention
|
Ctla4/tigit binding protein and pharmaceutical use thereof. Provided are a CTLA4/TIGIT binding pr... |
|
|
Invention
|
Fused heteroaryl compound, and preparation method therefor and use thereof in medicine. A fused h... |
